Monday, October 11, 2021 2:34:04 PM
Could be a conspiracy..
Recent CRVS News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 12:11:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 11:01:18 AM
- Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting • GlobeNewswire Inc. • 05/14/2026 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 09:02:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:01:38 PM
- Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 09:32:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 09:31:41 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:16:27 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 08:30:11 PM
- Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors • GlobeNewswire Inc. • 04/23/2026 11:30:00 AM
- Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting • GlobeNewswire Inc. • 04/21/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:46:18 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/13/2026 12:41:37 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/13/2026 12:02:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:02:29 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/12/2026 08:01:00 PM
- Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • GlobeNewswire Inc. • 03/05/2026 09:01:00 PM
- Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/23/2026 09:01:00 PM
- Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M • GlobeNewswire Inc. • 01/23/2026 10:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 11:06:06 AM
